Picture EBD Group Global Partnering Four Events One Price 650x80
Organisation › Details

Prilenia Therapeutics B.V.

Prilenia is a clinical stage biotech startup founded in 2018 with the purpose of improving the lives of patients and their families by developing treatments for neurodegenerative and neurodevelopmental disorders. Prilenia is based in Naarden, the Netherlands and Herzliya, Israel. *


Period Start 2020-06-01 established
  Group Prilenia (Group)
Products Industry pridopidine
  Industry 2 drug development
Persons Person Hayden, Michael R. (Prilenia Therapeutics 202006– CEO former President Global RnD + CSO at Teva)
  Person 2 Ben Har, Limor (Prilenia 202006 COO)
Region Region Naarden
  Country Netherlands
  City n. a. Naarden
    Address record changed: 2020-12-02
Basic data Employees n. a.
    * Document for �About Section�: Prilenia Therapeutics B.V.. (6/3/20). "Press Release: Prilenia Therapeutics Raises $62.5m to Fund Late Stage Trials in HD and ALS". Naarden & Herzliya.
Record changed: 2021-04-22


Picture [iito] Made Without Love 650x80px

More documents for Prilenia (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture [iito] Back into Ad 650x80px

» top